| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2025 | 20 May 2025 |
| Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended 31st March 2025. 2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Results of the Company for the Quarter/Year ended 31st March 2025. 3. To consider and approve the Audited Financial Statements including the Balance Sheet as at 31st March 2025 and the Statement of Profits and Loss and Cash flow statement of change in equity and notes thereon for the year ended 31st March 2025. 4. To Appoint Vishakha Agrawal & Associates Practicing Company Secretaries as the Secretarial Auditor of the Company for FY 2024-25. 5. Any other business with permission of the Chairman. Outcome of Board Meeting (As Per BSE Announcement Dated on: 29/05/2025) | ||
| Board Meeting | 14 May 2025 | 9 May 2025 |
| Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve To consider the appointment of Mr. Chintan Didawala Ganpat (DIN: 11088268) as Managing Director of the Company. 2. To consider the Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects. 3. To consider the Increase in the Authorized Share Capital of the Company and consequent amendment in Memorandum of the Company if any; 4. Conduct Postal Ballot by means of E-voting for obtaining approval of the members of the Company Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited Amendments to Memorandum of Association (As Per BSE Announcement Dated on 14.05.2025) | ||
| Board Meeting | 6 May 2025 | 6 May 2025 |
| Outcome of the Meeting of Board of Directors of Welcure Drugs & Pharmaceuticals Ltd.held on today i.e Tuesday 06th May 2025 | ||
| Board Meeting | 14 Feb 2025 | 10 Feb 2025 |
| WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Intimation of meeting of BOD under regulation 29 of the SEBI(LODR) Regulation 2015. Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on today i.e. Friday 14 February, 2025. OUTCOME OF THE MEETING OF THE BOARD OF DIRECTORS OF WELCURE DRUGS AND PHARMACEUTICALS LIMITED HELD ON TODAY 14 FEBRUARY 2025. (As Per BSE Announcement Dated on 14.02.2025) | ||
| Board Meeting | 22 Jan 2025 | 22 Jan 2025 |
| Outcome of the meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on today i.e. Wednesday, 22nd January, 2025 | ||
| Board Meeting | 2 Dec 2024 | 2 Dec 2024 |
| Outcome of the meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd. held on today i.e. Monday, 02nd December, 2024. | ||
| Board Meeting | 14 Nov 2024 | 7 Nov 2024 |
| WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Unaudited Financial Results of the Company for the 2nd quarter and half year ended on 30th September 2024 WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Board Meeting has been postponed and rescheduled to be held on Thursday, 14th November, 2024. (As per BSE Announcement Dated on 13/11/2024) Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on today i.e. Thursday, 14th November, 2024. (As Per BSE Announcement dated on 14.11.2024) | ||
| Board Meeting | 21 Oct 2024 | 17 Oct 2024 |
| WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2024 inter alia to consider and approve Forfeiture of 153900 Partly Paid-up Equity Shares. Outcome of Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd. (As Per BSE Announcement Dated on 21.10.2024) | ||
| Board Meeting | 4 Oct 2024 | 4 Oct 2024 |
| Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited. | ||
| Board Meeting | 2 Sep 2024 | 29 Aug 2024 |
| WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2024 inter alia to consider and approve Intimation of meeting of the Board of Directors under the Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Outcome of Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited (As per BSE Announcement Dated on 02/09/2024) | ||
| Board Meeting | 14 Aug 2024 | 6 Aug 2024 |
| WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Board Meeting Intimation Unaudited Fin Result along with Limited Review Report (As Per Bse Announcement Dated on 14.08.2024) | ||
| Board Meeting | 8 Aug 2024 | 8 Aug 2024 |
| Conversion of 3,29,99,997 warrants into equal number of equity shares of the Company on preferential basis | ||
| Board Meeting | 24 Jul 2024 | 24 Jul 2024 |
| Conversion of 3,30,00,000 warrants into equal number of equity shares of the Company on preferential basis | ||
| Board Meeting | 18 Jul 2024 | 18 Jul 2024 |
| Allotment of 9,90,00,000 Fully Convertible Warrants at Issue Price of Rs. 10/- on preferential basis | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.